a subsidiary of Mumbai-based Lupin, is recalling 6,16,506 bottles of Ramipril capsules in strengths of 2.5 mg, 5 mg and 10 mg, the US health regulator said. The affected lot is manufactured at ...

Pharmaceutical major Lupin has received approval from the United States Food and Drug Administration (FDA) for its generic drug capsules, 50 mg. The drug manufacturer can now market the generic ...

As per IQVIA MAT, Topiramate extended-release capsules had an estimated annual sale of USD 253 million in the US. Shares of Lupin ended 1.04 per cent lower at Rs 1,798 apiece on the BSE.

Mumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, ...

The pharma major said its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC‘s (a subsidiary of Pfizer Inc.) Celebrex capsules 50 mg, 100 mg ...

Shares of Lupin Ltd surged 2.38 per cent to ₹2,364.65 on the BSE at 11.27 AM and it reached an all-time high of ₹2,372.55 during the session. Lupin Ltd., a global pharmaceutical company ...

Lupin announced the acquisition of trademarks ... from the US health regulator to market Topiramate extended-release capsules in the US, said the company in an exchange filing.